Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001595888-25-000118
Filing Date
2025-08-19
Accepted
2025-08-19 16:52:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8525
  Complete submission text file 0001595888-25-000118.txt   10440
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Subject) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-42213 | Film No.: 251232620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 250 VESEY STREET 6TH FLOOR NEW YORK NY 10281
Business Address 250 VESEY STREET 6TH FLOOR NEW YORK NY 10281 212-651-6069
JANE STREET GROUP, LLC (Filed by) CIK: 0001595888 (see all company filings)

EIN.: 901010033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G